$TECH Income Statement | Understand Stock

$TECH

$72.60 -$0.09 (0.12%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Net sales
Cost of sales
Gross margin
Operating expenses:
Selling, general and administrative
Research and development
Total operating expenses
Operating income
Interest expense
Other income (expense):
Interest expense
Interest income
Other non-operating income (expense), net
Total other income (expense), net
Earnings before income taxes
Income taxes
Net earnings
Net earnings attributable to noncontrolling interest
Net earnings attributable to Bio-Techne
Other comprehensive income (loss):
Foreign currency translation income (loss)
Foreign currency translation reclassified to earnings with Eminence deconsolidation
Unrealized losses on derivative instruments
Other comprehensive income (loss)
Other comprehensive income (loss) attributable to noncontrolling interest
Other comprehensive income (loss) attributable to Bio-Techne
Comprehensive income

Earnings per share:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average common shares outstanding:
Basic (in shares)
Diluted (in shares)

Comments